Repaglinide, (-)-,
147852-26-4,
(R)-(-)-Repaglinide (Repaglinide Impurity),
AG-EE 624ZW,
AG-EE-624ZW,
UNII-85M30X62FM,
85M30X62FM,
(-)-Repaglinide,
2-Ethoxy-4-(2-(((1R)-3-methyl-1-(2-(piperidin-1-yl)phenyl)butyl)amino)-2-oxoethyl)benzoic acid,
2-ETHOXY-4-[2-[[(1R)-3-METHYL-1-[2-(PIPERIDIN-1-YL)PHENYL]BUTYL]AMINO]-2-OXOETHYL]BENZOIC ACID,
Repaglinide specified impurity E [EP],
CHEMBL151767,
SCHEMBL8141950,
CTK6G0993,
DTXSID70163818,
ZINC3831411,
R-Repaglinide (Repaglinide Impurity E),
ACM147852264,
Benzoic acid, 2-ethoxy-4-(2-(((1R)-3-methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethyl)-,
RT-015231,
FT-0674344,
J-008417,
2-Ethoxy-4-[2-[[(1R)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]benzoic Acid,
Repaglinide,
Repaglinide Impurity,
CID10479034,
A5316,
135062-02-1,